These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 1995185

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro study on the effects of fecal composition on fecapentaene kinetics in the large bowel.
    de Kok TM, van Iersel ML, ten Hoor F, Kleinjans JC.
    Mutat Res; 1993 Jun; 302(2):103-8. PubMed ID: 7684504
    [Abstract] [Full Text] [Related]

  • 7. Quantitative HPLC analysis of the level of fecapentaenes and their precursors in human feces by a chemical conversion method.
    Kivits GA, de Boer BC, Nugteren DH, van der Steeg M, Vertegaal LB, van der Gen A.
    J Nat Prod; 1990 Jun; 53(1):42-9. PubMed ID: 2348203
    [Abstract] [Full Text] [Related]

  • 8. Mutagenic activities of fecapentaene derivatives in the Ames/Salmonella test system.
    Peters JH, Riccio ES, Stewart KR, Reist EJ.
    Cancer Lett; 1988 Apr; 39(3):287-96. PubMed ID: 3282644
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combined chromatographic-isotopic dilution analysis of fecapentaenes in human feces.
    Peters JH, Nolen HW, Gordon GR, Bradford WW, Bupp JE, Reist EJ.
    J Chromatogr; 1989 Mar 24; 488(2):301-13. PubMed ID: 2663902
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fecapentaene excretion: aspects of excretion in newborn infants, children, and adult normal subjects and in adults maintained on total parenteral nutrition.
    Block JB, Dietrich MF, Leake R, Laidlaw SA, Vinton NE, Kopple JD.
    Am J Clin Nutr; 1990 Apr 24; 51(4):698-704. PubMed ID: 2108580
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Case-control study of colorectal cancer and fecapentaene excretion.
    Schiffman MH, Van Tassell RL, Robinson A, Smith L, Daniel J, Hoover RN, Weil R, Rosenthal J, Nair PP, Schwartz S.
    Cancer Res; 1989 Mar 01; 49(5):1322-6. PubMed ID: 2917361
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The precursors of fecapentaenes: purification and properties of a novel plasmalogen.
    Van Tassell RL, Piccariello T, Kingston DG, Wilkins TD.
    Lipids; 1989 May 01; 24(5):454-9. PubMed ID: 2755322
    [Abstract] [Full Text] [Related]

  • 18. Fecal mutagen fecapentaene-12 damages mammalian colon epithelial DNA.
    Hinzman MJ, Novotny C, Ullah A, Shamsuddin AM.
    Carcinogenesis; 1987 Oct 01; 8(10):1475-9. PubMed ID: 3652384
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of fecal mutagenicity and colorectal cancer risk.
    de Kok TM, van Maanen JM.
    Mutat Res; 2000 Jul 01; 463(1):53-101. PubMed ID: 10838209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.